How to buy Adamis Pharma stock

Adamis Pharma is a drug manufacturers-specialty & generic business based in the US. Adamis Pharma shares (ADMP) are listed on the NASDAQ and all prices are listed in US Dollars. Adamis Pharma employs 11 staff and has a trailing 12-month revenue of around $5 million.

Adamis Pharma stock price (NASDAQ: ADMP)

Use our graph to track the performance of ADMP stocks over time.

Adamis Pharma shares at a glance

• Key figures

Information last updated 2023-09-26.

Latest market close	$0.77
52-week range	$0.45 - $21.70
50-day moving average more info button	$1.14
200-day moving average more info button	$6.62
Wall St. target price	$0.42
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-10.14

Buy Adamis Pharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Adamis Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adamis Pharma price performance over time

Historical closes compared with the close of $0.7668 from 2023-09-26

1 week (2023-09-20)	31.53%
1 month (2023-08-25)	-7.37%
3 months (2023-06-27)	-64.99%
6 months (2023-03-27)	540.07%

1 year (2022-09-27)	199.65%
2 years (2021-09-27)	-25.55%
3 years (2020-09-25)	6.28%
5 years (2018-09-27)	4.025

Adamis Pharma financials

Revenue TTM	$5 million
Gross profit TTM	$-1,431,408
Return on assets TTM	-104.5%
Return on equity TTM	-784.96%
Profit margin	0%
Book value	$-4.24
Market Capitalization more info button	$7.3 million

TTM: trailing 12 months

Adamis Pharma share dividends

We're not expecting Adamis Pharma to pay a dividend over the next 12 months.

Have Adamis Pharma's shares ever split?

Adamis Pharma's shares were split on a 1:70 basis on 21 May 2023. So if you had owned 70 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharma shares – just the quantity. However, indirectly, the new 6900% higher share price could have impacted the market appetite for Adamis Pharma shares which in turn could have impacted Adamis Pharma's share price.

Adamis Pharma share price volatility

Over the last 12 months, Adamis Pharma's shares have ranged in value from as little as $0.4505 up to $21.7. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharma's is 1.2777. This would suggest that Adamis Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Adamis Pharma overview

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California. .

Frequently asked questions

What percentage of Adamis Pharma is owned by insiders or institutions?
Currently 7.811% of Adamis Pharma shares are held by insiders and 16.589% by institutions. How many people work for Adamis Pharma?
Latest data suggests 11 work at Adamis Pharma. When does the fiscal year end for Adamis Pharma?
Adamis Pharma's fiscal year ends in December. Where is Adamis Pharma based?
Adamis Pharma's address is: 11682 El Camino Real, San Diego, CA, United States, 92130 What is Adamis Pharma's ISIN number?
Adamis Pharma's international securities identification number is: US00547W2089 What is Adamis Pharma's CUSIP number?
Adamis Pharma's Committee on Uniform Securities Identification Procedures number is: 00547W109